marijuana stocks news

Cara Therapeutics to Webcast Presentation at the 15th Annual Needham Healthcare Conference

Cara Therapeutics, Inc. (CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors, today announced that Dr. Derek Chalmers, President and CEO, will present a company overview at the 15th Annual Needham Healthcare Conference on Tuesday, April 12, 2016, at 10:00 a.m. ET in New York City.

A live webcast of the presentation can be accessed under “Events and Presentations” in the News & Investors section of the Company’s website at www.CaraTherapeutics.com. An archived webcast recording will be available on the Cara website for approximately 30 days.

About Cara Therapeutics

Cara Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors. Cara is developing a novel and proprietary class of product candidates that target the body’s peripheral nervous system and have demonstrated efficacy in patients with moderate-to-severe pain without inducing many of the undesirable side effects typically associated with currently available pain therapeutics.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$PMCB Announces Launch of New Corporate Website

PharmaCyte Biotech Announces Launch of New Corporate Website SILVER SPRING, Md., March…

Two Rivers Water & Farming Company (TURV) Amends its Agreement to Purchase Three Hemp-focused Companies

Two Rivers Amends its Agreement to Purchase Three Hemp-focused Companies Two Rivers…

$GAWK Announced Another Signature Client Win

GAWK Customer Win HEMP, Inc. (OTC PINK: HEMP)  GAWK Inc. (OTC PINK:…

AbbVie Inc. (ABBV) Showcases its Leadership in Rheumatology Research with New Data

AbbVie Showcases its Leadership in Rheumatology Research with New Data Across Multiple…